Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Varex Imaging Corporation (VREX:NASDAQ), powered by AI.
Varex Imaging Corporation is currently trading at $10.50. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Varex Imaging Corporation on Alpha Lenz.
Varex Imaging Corporation's P/E ratio is -6.2.
“Varex Imaging Corporation trades at a P/E of -6.2 (undervalued) with modest ROE of -14.0%.”
Ask for details →Varex Imaging Corporation is a prominent company in the manufacturing and development of X-ray imaging components and solutions. Serving both medical and industrial sectors, Varex provides critical components like X-ray tubes, linear accelerators, and digital detectors which are integral to diagnostic imaging systems. These components are essential in medical diagnostics, providing high-resolution imaging for better patient care and efficient treatment planning. Beyond healthcare, Varex’s technologies are utilized in non-destructive testing, security inspection, and industrial quality control to ensure precision and safety. Established from a legacy of innovation, Varex Imaging leverages advanced research and development to maintain its position as a leading supplier in the global market. The company is pivotal in improving the performance and reliability of imaging systems, thereby enhancing the capabilities of original equipment manufacturers (OEMs) and healthcare providers. Its contributions are significant in the ongoing advancements in medical technology and industrial inspection, underscoring the company's role as a critical player in both preventive healthcare and safety engineering. Varex Imaging's expertise and broad application range underscore its market significance, making it a key entity in the imaging solutions industry.
“Varex Imaging Corporation trades at a P/E of -6.2 (undervalued) with modest ROE of -14.0%.”
Ask for details →Varex Imaging Corporation (ticker: VREX) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 2,300 employees. Market cap is $435M.
The current price is $10.5 with a P/E ratio of -6.18x and P/B of 0.92x.
ROE is -13.95% and operating margin is 7.83%. Annual revenue is $845M.